Depressive symptoms are a risk factor for all-cause mortality: Results from a prospective population-based study among 3,080 cancer survivors from the PROFILES registry

Journal of Cancer Survivorship

Volumn 7, Issue 3, 2013, Pages 484-492

  Mols, Floortje ^a,b   Husson, Olga ^a,b   Roukema, Jan Anne ^a,c   van de Poll Franse, Lonneke V ^a,b  

^a TILBURG UNIVERSITY   (Netherlands)

^b The Netherlands   (Netherlands)

^c CPRLab   (Netherlands)

Author keywords

Cancer; Depression; Depressive symptoms; Mortality

Indexed keywords

ADULT; AGED; ARTICLE; CAUSE OF DEATH; DEPRESSION; FEMALE; HUMAN; MALE; MIDDLE AGED; MORTALITY; NEOPLASM; NETHERLANDS; PSYCHOLOGICAL ASPECT; REGISTER; RISK FACTOR; STATISTICS; SURVIVOR; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CAUSE OF DEATH; DEPRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; NETHERLANDS; REGISTRIES; RISK FACTORS; SURVIVORS;

EID: 84881233717     PISSN: 19322259     EISSN: 19322267     Source Type: Journal    
DOI: 10.1007/s11764-013-0286-6     Document Type: Article

References (33)

1. Signaleringscommissie-Kanker, Kanker in Nederland. Trends, prognoses en implicaties voor zorgvraag. [Cancer in the Netherlands. Trends, prognosis and implications for health care.] 2004, KWF Kankerbestrijding: Amsterdam.
2. Ganz PA. Why and how to study the fate of cancer survivors: observations from the clinic and the research laboratory. Eur J Cancer. 2003;39(15): 2136-41.
3. Massie MJ. Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr. 2004;32: 57-71.
4. Satin JR, Linden W, Phillips MJ. Depression as a predictor of disease progression and mortality in cancer patients: a meta-analysis. Cancer. 2009;115(22): 5349-61.
5. Pinquart M, Duberstein PR. Depression and cancer mortality: a meta-analysis. Psychol Med. 2010;40(11): 1797-810.
6. Giese-Davis J, Collie K, Rancourt KM, Neri E, Kraemer HC, Spiegel D. Decrease in depression symptoms is associated with longer survival in patients with metastatic breast cancer: a secondary analysis. J Clin Oncol. 2011;29(4): 413-20.
7. Edelman S, Lemon J, Bell DR, Kidman AD. Effects of group CBT on the survival time of patients with metastatic breast cancer. Psychooncology. 1999;8(6): 474-81.
8. Cunningham AJ, Edmonds CV, Jenkins GP, Pollack H, Lockwood GA, Warr D. A randomized controlled trial of the effects of group psychological therapy on survival in women with metastatic breast cancer. Psychooncology. 1998;7(6): 508-17.
9. Goodwin PJ, Leszcz M, Ennis M, Koopmans J, Vincent L, Guther H, et al. The effect of group psychosocial support on survival in metastatic breast cancer. N Engl J Med. 2001;345(24): 1719-26.
10. Kissane DW, Love A, Hatton A, Bloch S, Smith G, Clarke DM, et al. Effect of cognitive-existential group therapy on survival in early-stage breast cancer. J Clin Oncol. 2004;22(21): 4255-60.
11. Spiegel D, Giese-Davis J. Depression and cancer: mechanisms and disease progression. Biol Psychiatry. 2003;54(3): 269-82.
12. Faller H, Schmidt M. Prognostic value of depressive coping and depression in survival of lung cancer patients. Psychooncology. 2004;13(5): 359-63.
13. Spiegel D. Mind matters in cancer survival. Psycho-Oncology. 2012;21(6): 588-93.
14. Arrieta, O., L. P. Angulo, C. Nunez-Valencia, Y. Dorantes-Gallareta, E. O. Macedo, D. Martinez-Lopez, S. Alvarado, J. F. Corona-Cruz, and L. F. Onate-Ocana. Association of depression and anxiety on quality of life, treatment adherence, and prognosis in patients with advanced non-small cell lung cancer. 2013. Ann Surg Oncol. doi: 10. 1245/s10434-012-2793-5.
15. Garssen B. Letter to the editor: depression linked to cancer mortality not convincingly demonstrated. Psychol Med. 2011;41(6): 1338-42.
16. van de Poll-Franse LV, Horevoorts N, Eenbergen MV, Denollet J, Roukema JA, Aaronson NK, et al. The Patient Reported Outcomes Following Initial treatment and Long term Evaluation of Survivorship registry: scope, rationale and design of an infrastructure for the study of physical and psychosocial outcomes in cancer survivorship cohorts. Eur J Cancer. 2011;47(14): 2188-94.
17. Janssen-Heijnen MLG, Louwman WJ, van de Poll-Franse LV, Coebergh JWW. Results of 50 years cancer registry in the South of the Netherlands: 1955-2004 (in Dutch). Eindhoven: Eindhoven Cancer Registry; 2005.
18. Nicolaije KA, Husson O, Ezendam NP, Vos MC, Kruitwagen RF, Lybeert ML, et al. Endometrial cancer survivors are unsatisfied with received information about diagnosis, treatment and follow-up: a study from the population-based PROFILES registry. Patient Educ Couns. 2012;88(3): 427-35.
19. Thong MS, Mols F, Lemmens VE, Rutten HJ, Roukema JA, Martijn H, et al. Impact of preoperative radiotherapy on general and disease-specific health status of rectal cancer survivors: a population-based study. Int J Radiat Oncol Biol Phys. 2011;81(3): e49-58.
20. Thong MS, Mols F, Lemmens VE, Creemers GJ, Slooter GD, van de Poll-Franse LV. Impact of chemotherapy on health status and symptom burden of colon cancer survivors: a population-based study. Eur J Cancer. 2011;47(12): 1798-807.
21. Oerlemans S, Mols F, Issa DE, Pruijt JH, Peters WG, Lybeert M, et al. A high level of fatigue among long-term survivors of non-Hodgkin's lymphoma: results from the longitudinal population-based PROFILES registry in the south of the Netherlands. Haematologica. 2013;98(3): 479-86.
22. Mols F, Oerlemans S, Vos AH, Koster A, Verelst S, Sonneveld P, et al. Health-related quality of life and disease-specific complaints among multiple myeloma patients up to 10 yr after diagnosis: results from a population-based study using the PROFILES registry. Eur J Haematol. 2012;89(4): 311-9.
23. UICC. TNM atlas illustrated guide to the TNM/pTNM classification of malignant tumors. 4th ed. Berlin: Springer; 1992. p. 141-4. 2nd Revision ed.
24. van Duijn C, Keij I. Sociaal-economische status indicator op postcode niveau. Maandstatistiek van de bevolking. 2002;50: 32-5.
25. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6): 361-70.
26. Olsson I, Mykletun A, Dahl AA. The Hospital Anxiety and Depression Rating Scale: a cross-sectional study of psychometrics and case finding abilities in general practice. BMC Psychiatry. 2005;5: 46.
27. Sangha O, Stucki G, Liang MH, Fossel AH, Katz JN. The self-administered comorbidity questionnaire: a new method to assess comorbidity for clinical and health services research. Arthritis Rheum. 2003;49(2): 156-63.
28. Mols F, Oerlemans S, Denollet J, Roukema JA, van de Poll-Franse LV. Type D personality is associated with increased comorbidity burden and health care utilization among 3080 cancer survivors. Gen Hosp Psychiatry. 2012;34(4): 352-9. doi: 10. 1016/j. genhosppsych. 2012. 01. 014.
29. Coyne JC, Palmer SC, Shapiro PJ, Thompson R, DeMichele A. Distress, psychiatric morbidity, and prescriptions for psychotropic medication in a breast cancer waiting room sample. Gen Hosp Psychiatry. 2004;26(2): 121-8.
30. Fechner-Bates S, Coyne JC, Schwenk TL. The relationship of self-reported distress to depressive disorders and other psychopathology. J Consult Clin Psychol. 1994;62(3): 550-9.
31. Cosco TD, Doyle F, Watson R, Ward M, McGee H. Mokken scaling analysis of the Hospital Anxiety and Depression Scale in individuals with cardiovascular disease. Gen Hosp Psychiatry. 2012;34(2): 167-72.
32. Coyne JC, van Sonderen E. The Hospital Anxiety and Depression Scale (HADS) is dead, but like Elvis, there will still be citings. J Psychosom Res. 2012;73(1): 77-8.
33. Coyne JC, van Sonderen E. No further research needed: abandoning the Hospital and Anxiety Depression Scale (HADS). J Psychosom Res. 2012;72(3): 173-4.